Circulating Soluble Fms-like Tyrosine Kinase in Renal Diseases Other than Preeclampsia

Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix

(2020) Kyle H. Moore et al.   Biology of Sex Differences

Increased soluble fms-like tyrosine kinase 1 after ischemia reperfusion contributes to adverse clinical outcomes following kidney transplantation

(2019) Theresa M. Wewers et al.   KIDNEY INTERNATIONAL

The Association of Angiogenesis Markers With Acute Kidney Injury and Mortality After Cardiac Surgery

(2019) Sherry G. Mansour et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Placenta growth factor and sFlt-1 as biomarkers in ischemic heart disease and heart failure: a review

(2019) Nicole Draker et al.   Biomarkers in Medicine

Heparanase regulation of sFLT-1 release in trophoblasts in vitro

(2019) Adrian C. Eddy et al.   PLACENTA

Positive and Negative Regulation of Angiogenesis by Soluble Vascular Endothelial Growth Factor Receptor-1

(2018) Cristina Failla et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Ascending Vasa Recta Are Angiopoietin/Tie2-Dependent Lymphatic-Like Vessels

(2017) Yael Kenig-Kozlovsky et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Heparanase: roles in cell survival, extracellular matrix remodelling and the development of kidney disease

(2017) Ton J. Rabelink et al.   Nature Reviews Nephrology

Vascular Growth Factors and Glomerular Disease

(2016) Christina S. Bartlett et al.   Annual Review of Physiology

Role of endothelin in preeclampsia and hypertension following antiangiogenesis treatment

(2016) Langeza Saleh et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Suppressed Production of Soluble Fms-Like Tyrosine Kinase-1 Contributes to Myocardial Remodeling and Heart FailureNovelty and Significance

(2016) Ayako Seno et al.   HYPERTENSION

Soluble fms-like tyrosine kinase 1 promotes angiotensin II sensitivity in preeclampsia

(2016) Suzanne D. Burke et al.   JOURNAL OF CLINICAL INVESTIGATION

Oxidative stress-induced Gadd45α inhibits trophoblast invasion and increases sFlt1/sEng secretions via p38 MAPK involving in the pathology of pre-eclampsia

(2016) Xiru Liu et al.   Journal of Maternal-Fetal & Neonatal Medicine

Nuclear factor of activated T-cells (NFAT) regulates soluble fms-like tyrosine kinase-1 secretion (sFlt-1) from human placenta

(2016) Louie Ye et al.   PLACENTA

Both Vascular Endothelial Growth Factor and Soluble Flt-1 Are Increased in Type 2 Diabetes But Not in Impaired Fasting Glucose

(2016) Debashis Nandy et al.   JOURNAL OF INVESTIGATIVE MEDICINE

Soluble Flt-1 links microvascular disease with heart failure in CKD

(2015) Giovana S. Di Marco et al.   BASIC RESEARCH IN CARDIOLOGY

Hypoxia-Independent Upregulation of Placental Hypoxia Inducible Factor-1α Gene Expression Contributes to the Pathogenesis of PreeclampsiaNovelty and Significance

(2015) Takayuki Iriyama et al.   HYPERTENSION

Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia

(2015) R. Thadhani et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Association of vascular endothelial factors with cardiovascular outcome and mortality in chronic kidney disease patients: A 4-year cohort study

(2014) Mehdi Rambod et al.   ATHEROSCLEROSIS

Tubulovascular Cross-Talk by Vascular Endothelial Growth Factor A Maintains Peritubular Microvasculature in Kidney

(2014) H. Dimke et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Heparin use during dialysis sessions induces an increase in the antiangiogenic factor soluble Flt1

(2014) Frédéric Lavainne et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Elevated Soluble VEGF Receptor sFlt-1 Correlates with Endothelial Injury in IgA Nephropathy

(2014) Ya-Ling Zhai et al.   PLoS One

Suppressed soluble Fms–like tyrosine kinase-1 production aggravates atherosclerosis in chronic kidney disease

(2013) Masaru Matsui et al.   KIDNEY INTERNATIONAL

Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients

(2013) J. Yuan et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Increased Soluble Flt-1 Correlates With Delayed Graft Function and Early Loss of Peritubular Capillaries in the Kidney Graft

(2013) Marion Chapal et al.   TRANSPLANTATION

Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia/hypoxia: role of tumor necrosis factor-α

(2012) Sydney R. Murphy et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Soluble FLT1 Binds Lipid Microdomains in Podocytes to Control Cell Morphology and Glomerular Barrier Function

(2012) Jing Jin et al.   CELL

eNOS Deficiency Acts through Endothelin to Aggravate sFlt-1-Induced Pre-Eclampsia-Like Phenotype

(2012) F. Li et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Cardiac angiogenic imbalance leads to peripartum cardiomyopathy

(2012) Ian S. Patten et al.   NATURE

Heparin Strongly Induces Soluble Fms-Like Tyrosine Kinase 1 Release In Vivo and In Vitro—Brief Report

(2011) Julia Searle et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Heparin Elevates Circulating Soluble fms-Like Tyrosine Kinase-1 Immunoreactivity in Pregnant Women Receiving Anticoagulation Therapy

(2011) Victor A. Rosenberg et al.   CIRCULATION

Local Retention Versus Systemic Release of Soluble VEGF Receptor-1 Are Mediated by Heparin-Binding and Regulated by Heparanase

(2011) Shay Sela et al.   CIRCULATION RESEARCH

The Vascular Marker Soluble Fms-Like Tyrosine Kinase 1 Is Associated With Disease Severity and Adverse Outcomes in Chronic Heart Failure

(2011) Bonnie Ky et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Elevated Soluble Flt1 Inhibits Endothelial Repair in PR3-ANCA-Associated Vasculitis

(2011) S. Le Roux et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Early Loss of Peritubular Capillaries after Kidney Transplantation

(2011) F. M. E. G. Steegh et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling

(2010) T. Cindrova-Davies et al.   CARDIOVASCULAR RESEARCH

Role of Vascular Endothelial Growth Factor in Kidney Disease

(2010) Kent Doi et al.   Current Vascular Pharmacology

Proteases and sFlt-1 Release in the Human Placenta

(2010) S. Zhao et al.   PLACENTA

Usefulness of Soluble Fms-like Tyrosine Kinase-1 as a Biomarker of Acute Severe Heart Failure in Patients With Acute Myocardial Infarction

(2009) Kenji Onoue et al.   AMERICAN JOURNAL OF CARDIOLOGY

Inhibition of VEGF or TGF-β Signaling Activates Endothelium and Increases Leukocyte Rolling

(2009) Tony E. Walshe et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Identification of Ligand-Induced Proteolytic Cleavage and Ectodomain Shedding of VEGFR-1/FLT1 in Leukemic Cancer Cells

(2009) N. Rahimi et al.   CANCER RESEARCH

Reduction of Circulating Soluble Fms-Like Tyrosine Kinase-1 Plays a Significant Role in Renal Dysfunction–Associated Aggravation of Atherosclerosis

(2009) Kenji Onoue et al.   CIRCULATION

Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model

(2009) Astrid Bergmann et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

The Soluble VEGF Receptor sFlt1 Contributes to Endothelial Dysfunction in CKD

(2009) G. S. D. Marco et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Associations of VEGF and its receptors sVEGFR-1 and -2 with cardiovascular disease and survival in prevalent haemodialysis patients

(2009) Q. Guo et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Inducible Overexpression of sFlt-1 in Podocytes Ameliorates Glomerulopathy in Diabetic Mice

(2008) C.-H. Ku et al.   DIABETES

VEGF Inhibition and Renal Thrombotic Microangiopathy

(2008) Vera Eremina et al.   NEW ENGLAND JOURNAL OF MEDICINE

Placenta growth factor expression in human atherosclerotic carotid plaques is related to plaque destabilization

(2006) Kevin Pilarczyk et al.   ATHEROSCLEROSIS